LYZ and bacterial infectious disease with sepsis: Nevertheless, the activity empowerment was quite variable: in the case of lysozyme + colistin, the ranges of fold-reduction in viability were 5.8–821.3 for bacteremia, and 6.9–145.5 for CF isolates.